David R. Healy

512 total citations
11 papers, 343 citations indexed

About

David R. Healy is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, David R. Healy has authored 11 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Orthopedics and Sports Medicine. Recurrent topics in David R. Healy's work include Bone health and treatments (4 papers), Parathyroid Disorders and Treatments (3 papers) and Bone health and osteoporosis research (3 papers). David R. Healy is often cited by papers focused on Bone health and treatments (4 papers), Parathyroid Disorders and Treatments (3 papers) and Bone health and osteoporosis research (3 papers). David R. Healy collaborates with scholars based in United States, Croatia and Germany. David R. Healy's co-authors include Thomas A. Brown, David D. Thompson, David T. Crawford, Hua Zhu Ke, Hollis A. Simmons, Vishwas Paralkar, Lydia C. Pan, Yan Li, Hong Qi and Bruce A. Lefker and has published in prestigious journals such as Journal of the American Society of Nephrology, Journal of Pharmacology and Experimental Therapeutics and Journal of Bone and Mineral Research.

In The Last Decade

David R. Healy

11 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Healy United States 9 153 91 88 83 64 11 343
Kevin Greenslade United Kingdom 9 261 1.7× 129 1.4× 120 1.4× 40 0.5× 58 0.9× 10 464
Martine Bisson Canada 13 264 1.7× 155 1.7× 47 0.5× 24 0.3× 57 0.9× 15 430
N Sarlet Belgium 10 164 1.1× 118 1.3× 215 2.4× 45 0.5× 66 1.0× 26 414
Shin-Long Wu Taiwan 8 305 2.0× 53 0.6× 53 0.6× 28 0.3× 31 0.5× 10 476
Haruki Odagiri Japan 13 128 0.8× 68 0.7× 80 0.9× 21 0.3× 19 0.3× 14 562
Zhihua Wen China 9 325 2.1× 141 1.5× 71 0.8× 26 0.3× 19 0.3× 15 483
Zhenyu Shi China 12 208 1.4× 72 0.8× 97 1.1× 53 0.6× 18 0.3× 27 366
Yazeng Huang China 12 262 1.7× 74 0.8× 58 0.7× 49 0.6× 11 0.2× 39 562
WELDON LLOYD United States 11 165 1.1× 134 1.5× 33 0.4× 54 0.7× 35 0.5× 18 357
Cara S. Nestlerode United States 13 212 1.4× 76 0.8× 106 1.2× 7 0.1× 111 1.7× 20 410

Countries citing papers authored by David R. Healy

Since Specialization
Citations

This map shows the geographic impact of David R. Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Healy more than expected).

Fields of papers citing papers by David R. Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Healy. The network helps show where David R. Healy may publish in the future.

Co-authorship network of co-authors of David R. Healy

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Healy. A scholar is included among the top collaborators of David R. Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Healy. David R. Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Jové, Veronica, Heather E. Wheeler, David R. Healy, et al.. (2024). Type I interferon regulation by USP18 is a key vulnerability in cancer. iScience. 27(4). 109593–109593. 6 indexed citations
2.
Abraham, Anson K., Tristan S. Maurer, Amit S. Kalgutkar, et al.. (2011). Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing Receptor. The AAPS Journal. 13(2). 265–273. 9 indexed citations
3.
Grgurević, Lovorka, Boris Maček, David R. Healy, et al.. (2011). Circulating Bone Morphogenetic Protein 1–3 Isoform Increases Renal Fibrosis. Journal of the American Society of Nephrology. 22(4). 681–692. 48 indexed citations
4.
Bauman, Jonathan, David A. Price, Paul S. Humphries, et al.. (2010). Metabolism-Guided Design of Short-Acting Calcium-Sensing Receptor Antagonists. ACS Medicinal Chemistry Letters. 1(5). 219–223. 10 indexed citations
5.
Paralkar, Vishwas, Lovorka Grgurević, Amy Brault, et al.. (2010). A novel role of bone morphogenetic protein-6 (BMP-6) as an endocrine regulator of bone and glucose homeostasis. Bone. 47. S57–S57. 1 indexed citations
6.
Abraham, Anson K., Donald E. Mager, Xiang Gao, et al.. (2009). Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Parathyroid Hormone-Calcium Homeostasis in Rats and Humans. Journal of Pharmacology and Experimental Therapeutics. 330(1). 169–178. 20 indexed citations
7.
Pan, Lydia C., Hollis A. Simmons, David R. Healy, et al.. (2006). Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice. Bone. 39(4). 796–806. 42 indexed citations
8.
Healy, David R., Hollis A. Simmons, David T. Crawford, et al.. (2005). Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone. 37(1). 46–54. 64 indexed citations
9.
Healy, David R., et al.. (2004). Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.. PubMed. 4(1). 22–32. 11 indexed citations
10.
Li, Mei, Hua Zhu Ke, Hong Qi, et al.. (2003). A Novel, Non-Prostanoid EP2 Receptor-Selective Prostaglandin E2 Agonist Stimulates Local Bone Formation and Enhances Fracture Healing. Journal of Bone and Mineral Research. 18(11). 2033–2042. 97 indexed citations
11.
Shen, V., X.G. Liang, R. Birchman, et al.. (1997). Short term immobilization-induced cancellous bone loss is limited to regions undergoing high turnover and/or modeling in mature rats. Bone. 21(1). 71–78. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026